Berger Financial Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.84M | Buy |
61,701
+415
| +0.7% | +$46K | 0.44% | 46 |
|
|
2025
Q1 | $6.87M | Buy |
+61,286
| New | +$6.87M | 0.48% | 45 |
|
|
2023
Q2 | – | Sell |
-2,508
| Closed | -$208K | – | 288 |
|
|
2023
Q1 | $208K | Sell |
2,508
-69,721
| -97% | -$5.79M | 0.03% | 259 |
|
|
2022
Q4 | $6.2M | Buy |
72,229
+853
| +1% | +$73.2K | 0.82% | 30 |
|
|
2022
Q3 | $4.4M | Buy |
71,376
+2,225
| +3% | +$137K | 0.65% | 41 |
|
|
2022
Q2 | $4.27M | Buy |
69,151
+1,511
| +2% | +$93.4K | 0.62% | 47 |
|
|
2022
Q1 | $4.02M | Buy |
+67,640
| New | +$4.02M | 0.51% | 60 |
|
|
2021
Q1 | – | Sell |
-57,942
| Closed | -$3.38M | – | 211 |
|
|
2020
Q4 | $3.38M | Buy |
+57,942
| New | +$3.38M | 0.59% | 66 |
|